Literature DB >> 1623805

Bronchiolitis obliterans organizing pneumonia: definition and clinical features.

G R Epler1.   

Abstract

There are several bronchiolar diseases with different pathologic and clinical findings. Idiopathic BOOP is a distinct entity consisting of a flu-like illness, late inspiratory crackles, patchy infiltrates roentgenographically, and physiologically decreased vital capacity and diffusing capacity. Response to corticosteroid therapy is good and relapse does not occur if sufficient therapy is given. Bronchiolitis obliterans organizing pneumonia is an appropriate description of this entity. The term is specific because it includes bronchioles and alveoli and excludes disorders involving only alveoli such as organizing pneumonitis or organizing diffuse alveolar damage. The term is general enough to include a sufficient number of patients with a homogenous disorder. Furthermore, the entity can be described to clinicians and pathologists throughout the world in such a fashion that patient care and research can be standardized. Researchers from different centers studying the cause or utilizing treatment protocols are able to discuss a single BOOP entity rather than comparing results of a heterogeneous group of many different types of interstitial lung disorders. This will lead to breakthroughs in discovery of etiologic causes and new effective therapeutic regimens.

Entities:  

Mesh:

Year:  1992        PMID: 1623805     DOI: 10.1378/chest.102.1_supplement.2s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Organising pneumonia presenting as acute life threatening pulmonary haemorrhage.

Authors:  Damodhara Honnavally Narasimhaiah; Indranil Chakravorty; Rajiv Swamy; Doraiswamy Prakash
Journal:  BMJ Case Rep       Date:  2011-11-08

2.  Juvenile rheumatoid arthritis and bronchiolitis obliterans organized pneumonia.

Authors:  Debora Ingrid Sohn; Hugo Armando Laborde; Marta Bellotti; Luis Seijo
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

Review 3.  Organizing pneumonia: a kaleidoscope of concepts and morphologies.

Authors:  Benjamin J Roberton; David M Hansell
Journal:  Eur Radiol       Date:  2011-07-10       Impact factor: 5.315

4.  Intravenous immune globulins (IVIg) treatment for organizing pneumonia in a selective IgG immune deficiency state.

Authors:  Itai Gueta; Yehuda Shoenfeld; Hedi Orbach
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

5.  Respiratory reovirus 1/L induction of intraluminal fibrosis. A model for the study of bronchiolitis obliterans organizing pneumonia.

Authors:  S C Bellum; D Dove; R A Harley; W B Greene; M A Judson; L London; S D London
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

6.  Aseptic systemic abscesses preceding diagnosis of Crohn's disease by three years.

Authors:  M Andre; O Aumaitre; J C Marcheix; J C Piette
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

7.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study.

Authors:  José Luis López-Campos; Eulogio Rodríguez-Becerra
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

9.  Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes.

Authors:  Elizabeth I Majeski; Manjeet K Paintlia; Andrea D Lopez; Russell A Harley; Steven D London; Lucille London
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis.

Authors:  E S Strobel; R B Bonnet; P Werner; H E Schaefer; H H Peter
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.